Climb Bio, Inc.

NASDAQ:CLYM

Biotechnology

Healthcare
$9.78 +0.17%

+$0.02 today

Market cap
$574.46M
Beta
0.10
P/E (TTM)
-14.7
EPS (TTM)
-$0.77
52W Low $1.17High $12.48

Volume 0.59M

Average 0.88M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$67.88M

FY 2025 · Annual

Net Income

-$59.85M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue000097K
Gross Profit0000(97K)
Gross Margin—————
Research & Development23.32M26.21M15.41M14.34M46.62M
Selling, General & Admin12.35M18.92M24.86M16.03M21.17M
Operating Expenses35.67M45.14M40.28M82.02M67.79M
Depreciation & Amortization000097K
EBITDA(47.48M)(45.24M)(35.12M)(30.36M)(59.75M)
EBITDA Margin—————
Operating Income(35.67M)(45.14M)(40.28M)(82.02M)(67.88M)
Operating Margin—————
Interest Income01.38M4.62M8.13M8.32M
Interest Expense00000
Other Income / Expenses(11.81M)(109K)5.16M8.12M8.03M
Income Before Tax(47.48M)(45.24M)(35.12M)(73.9M)(59.85M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(47.48M)(45.24M)(35.12M)(73.9M)(59.85M)
Net Margin—————
EPS (Basic)(4.24)(1.72)(1.30)(1.53)(0.88)
EPS (Diluted)(4.24)(1.72)(1.30)(1.53)(0.88)
Weighted Avg Shares12.26M26.31M26.99M48.16M67.81M
Weighted Avg Shares (Diluted)12.26M26.31M26.99M48.16M67.81M

CLYM Earnings Waterfall · TTM

NASDAQ:CLYM · Revenue to Net Income

Key Ratios

EPS$-0.78
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-4.4
P/S Ratio0.0

Analysis

$0 of revenue converted into -$52.8M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-0.78, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13D/ASC 13D/A filingNov 9, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
S-3ASRS-3ASR filingNov 5, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026

How much revenue does CLYM generate?

Climb Bio, Inc. (CLYM) reported $0.00 of revenue in fiscal 2025.

Is CLYM profitable?

Climb Bio, Inc. (CLYM) reported -$59.85M of net income.